Erratum: “Review of kerma‐area product, effective dose and dose conversion coefficients for non‐cardiac interventional fluoroscopy procedures” [Med. Phys. 47, 975‐982 (2020),Medical Physics

当前位置： X-MOL 学术 › Med Phys › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Erratum: “Review of kerma‐area product, effective dose and dose conversion coefficients for non‐cardiac interventional fluoroscopy procedures” [Med. Phys. 47, 975‐982 (2020)
Medical Physics ( IF 3.8 ) Pub Date : 2020-10-11 , DOI: 10.1002/mp.14458
Donald L. Miller ₁

Affiliation

The units for air kerma‐area product (P_KA) and dose conversion coefficient (DC_E) in this article¹ were correct in the manuscript and published Accepted Article but were inadvertently changed during the copyediting process. The correct unit for P_KA is Gy cm², sometimes written as Gy·cm². The correct unit for DC_E is therefore mSv (Gy cm²) ^–1. Dose is multiplied by area, not divided. The incorrect units (Gy/cm² and mSv (Gy/cm²)^–1) appear on pages 977 and 979 and in Tables I and III. These changes were not brought to the attention of the author and were missed when the galley proofs were reviewed.

The Results and Conclusions of this article are unchanged.

Table I. Variation in reported air kerma‐area product (P_KA) and average P_KA for a variety of interventional fluoroscopy procedures.

Examination	Range of average^a ^a Average values may be reported in the literature as either mean or median values; both mean and median are not commonly reported. P_KA values (Gy cm²) reported in the literature	Reference	Range of P_KA values (Gy cm²) for individual cases reported in the literature	Reference
Abdominal diagnostic angiography or aortography	42.8–347	^{5,9,17,19,23,24,31}	0.3–2388	^5,9,19,23,31
Abdominal arterial interventions	1.5–792	^{5–10,13,19,22–24,28,30,31,34–36,38,50,61,79}	0.9–2182	^{5,9,13,19,22,23,29–31,34–36,38,50,79}
Biliary interventions	4.4–213	^{5,7,9,10,13,16,23,24,27,28,30,31,61}	0.03–620.9	^{5,9,13,16,23,29–31}
Percutaneous intestinal access	2.2–44.1	^{5–7,9,13,24}	0.02–308.8	^5,9,13
Head and/or neck diagnostic angiography	21–242	^{6,9,10,12,15,17,19,22,30,31}	13–4131	^{9,12,17,19,22,30,31}
Head and/or neck vascular interventions	130.8–531	^{9,10,12,15,19,21,30,31}	25–2036	^{9,12,19,21,30,31,74}
Hysterosalpingography	0.41–4.5	^9,26	0.17–99.4	^9,26
Inferior vena cava filter placement	10.4–102.9	^6,9,13,24	12.2–363.9	^9,13
Lower extremity diagnostic angiography	31.5–123	^{6,8–10,17,22,31,61}	0.25–608	^{9,17,22,29,31}
Lower extremity vascular interventions	52–203.8	^{6,8,9,23,24,28,30,31}	3.6–874	^{9,17,23,30,31}
Nonvascular kidney access/interventions	4.8–121.5	^{5,6,9,13,23,24,30,31,60}	0.006–525.8	^{5,9,13,23,24,30,31,60}
Pelvic diagnostic angiography	123–124	^9,19	16–570.7	^9,19
Pelvic vascular interventions	23.4–335.9	^{6,8–10,14,19,24,28,30,61}	8.8–1136	^{9,14,19,29,30}
Venous access	0.4–2	^5,6,10,13,24	0.01–88.8	^5,13,24
Vertebral augmentation	2.8–129	^{9,10,13,15,30,52,53}	18.8–382.7	^9,30

^a Average values may be reported in the literature as either mean or median values; both mean and median are not commonly reported.

Table III. Variation in reported DC_E for a variety of interventional fluoroscopy procedures.

Examination	Suggested DC_E (mSv (Gy cm²) ^–1)	DC_E Values (mSv (Gy cm²) ^–1) Reported in the Literature^a ^a These values are either reported values for DC_E or values of DC_E calculated from data in studies where values of both P_KA and E were reported but DC_E was not provided. DC_E values may be reported in the literature by using tissue weighting factors from ICRP Publication 60 ⁴⁷ or ICRP Publication 103 ⁴⁰; use of both sets of tissue weighting factors to report both values of effective dose is not common.	Reference
Abdominal diagnostic or interventional vascular procedures	0.17	0.13, 0.14, 0.144, 0.145, 0.15, 0.18, 0.20, 0.21, 0.22, 0.25, 0.16–0.26	^{13,19,23,30,31,34–37}
Biliary interventions	0.17	0.089, 0.15, 0.19, 0.25	^20,23,30,31
Percutaneous intestinal access	0.22	0.22	⁹
Head and/or neck diagnostic angiography and vascular interventions	0.10	0.022–0.044, 0.07, 0.1, 0.08–0.12, 0.15	^12,19,30,31
Hysterosalpingography	0.40	0.37, 0.56	^14,26
Lower extremity diagnostic or interventional vascular procedures	0.01	0.005, 0.01, 0.11, 0.23	^9,23,30,31
Nonvascular kidney access/interventions	0.20	0.089, 0.20, 0.25	^20,23,30,31
Vertebral augmentation	0.09	0.02, 0.09, 0.23, 0.39	^30,52–54

^a These values are either reported values for DC_E or values of DC_E calculated from data in studies where values of both P_KA and E were reported but DC_E was not provided. DC_E values may be reported in the literature by using tissue weighting factors from ICRP Publication 60 ⁴⁷ or ICRP Publication 103 ⁴⁰; use of both sets of tissue weighting factors to report both values of effective dose is not common.

中文翻译：

勘误表：“对于非心脏介入性透视检查程序，评价角膜区域积，有效剂量和剂量转换系数” [医学杂志。物理 47，975-982（2020）

本文第¹条中的空气比释动能积（P _KA）和剂量转换系数（DC _E）的单位在手稿中是正确的，并已发布在“接受的文章”中，但在复制编辑过程中无意中进行了更改。P _KA的正确单位是Gy cm ²，有时写为Gy·cm ²。因此，DC _E的正确单位是mSv（Gy cm ²）^–1。剂量乘以面积，而不是除以。错误的单位（Gy / cm ²和mSv（Gy / cm ²）^–1）出现在977和979页以及表I和III中。这些变化没有引起作者的注意，并且在检查厨房证据时被遗漏了。

本文的结果和结论保持不变。

表I.各种介入荧光检查程序的报告的空气比释动能面积（P _KA）和平均P _KA的变化。

检查	平均范围^一 ^a 平均值可在文献中以均值或中位数报告；均值和中位数均不经常报告。文献报道的P _KA值（Gy cm ²）	参考	文献报道的个别病例的P _KA值范围（Gy cm ²）	参考
腹部诊断血管造影或主动脉造影	42.8–347	^{5,9,17,19,23,24,31}	0.3–2388	^5,9,19,23,31
腹部动脉介入	1.5–792	^{5–10,13,19,22–24,28,30,31,34–36,38,50,61,79}	0.9–2182	^{5,9,13,19,22,23,29–31,34–36,38,50,79}
胆道干预	4.4–213	^{5,7,9,10,13,16,23,24,27,28,30,31,61}	0.03–620.9	^{5,9,13,16,23,29–31}
经皮肠通路	2.2–44.1	^{5–7,9,13,24}	0.02–308.8	^5,9,13
头和/或颈诊断血管造影	21–242	^{6,9,10,12,15,17,19,22,30,31}	13–4131	^{9,12,17,19,22,30,31}
头和/或颈血管干预	130.8–531	^{9,10,12,15,19,21,30,31}	25–2036	^{9,12,19,21,30,31,74}
子宫输卵管造影	0.41–4.5	^9,26	0.17–99.4	^9,26
下腔静脉滤器放置	10.4–102.9	^6,9,13,24	12.2–363.9	^9,13
下肢诊断性血管造影	31.5–123	^{6,8–10,17,22,31,61}	0.25–608	^{9,17,22,29,31}
下肢血管介入	52–203.8	^{6,8,9,23,24,28,30,31}	3.6–874	^{9,17,23,30,31}
非血管肾通路/干预	4.8–121.5	^{5,6,9,13,23,24,30,31,60}	0.006–525.8	^{5,9,13,23,24,30,31,60}
骨盆诊断血管造影	123–124	^9,19	16–570.7	^9,19
盆腔血管干预	23.4–335.9	^{6,8–10,14,19,24,28,30,61}	8.8–1136	^{9,14,19,29,30}
静脉通路	0.4–2	^5,6,10,13,24	0.01–88.8	^5,13,24
椎体隆隆	2.8–129	^{9,10,13,15,30,52,53}	18.8–382.7	^9,30

^a 平均值可在文献中以均值或中位数报告；均值和中位数均不经常报告。

表III。对于各种介入性透视检查程序，报告的DC _E有所变化。

检查	建议的DC _E（mSv（Gy cm ²）^–1）	DC _ë值（毫希（戈瑞厘米²）^-1在文献中报道）^一 ^一个这些值要么报道DC值_ê或DC的值_ê从其中两个的值在研究的数据计算出的P _KA和ë被报道，但DC_Ë未提供。DC_E值可在文献中通过使用来自ICRP出版物60⁴⁷或ICRP出版物103^40的组织加权因子进行报告。使用两组组织加权因子来报告两个有效剂量值并不常见。	参考
腹部诊断或介入性血管手术	0.17	0.13、0.14、0.144、0.145、0.15、0.18、0.20、0.21、0.22、0.25、0.16-0.26	^{13,19,23,30,31,34–37}
胆道干预	0.17	0.089、0.15、0.19、0.25	^20,23,30,31
经皮肠通路	0.22	0.22	⁹
头和/或颈诊断性血管造影和血管干预	0.10	0.022–0.044、0.07、0.1、0.08–0.12、0.15	^12,19,30,31
子宫输卵管造影	0.40	0.37、0.56	^14,26
下肢诊断或介入性血管手术	0.01	0.005、0.01、0.11、0.23	^9,23,30,31
非血管肾通路/干预	0.20	0.089、0.20、0.25	^20,23,30,31
椎体隆隆	0.09	0.02、0.09、0.23、0.39	^30,52–54